Finance

Beta
Lists
OCSL:NASDAQ
Oaktree Specialty Lending Corp
$11.69
+2.45%
(+0.28) 1D
Jun 26, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OCSL...
Open
$11.38
High
$11.70
Low
$11.38
Mkt. cap
1.03B
Avg. vol.
627.48K
Volume
652.88K
Dividend
10.27%
Quarterly dividend
$0.30
Ex-dividend date
Jun 15, 2026
P/E ratio
20.74
52-wk high
$14.76
52-wk low
$10.63
EPS
$0.56
Beta
0.54
Shares outstanding
88.09M
No. of employees
0
Open
$11.38
High
$11.70
Low
$11.38
Mkt. cap
1.03B
Avg. vol.
627.48K
Volume
652.88K
Dividend
10.27%
Quarterly dividend
$0.30
Ex-dividend date
Jun 15, 2026
P/E ratio
20.74
52-wk high
$14.76
52-wk low
$10.63
EPS
$0.56
Beta
0.54
Shares outstanding
88.09M
No. of employees
0
News stories
From sources across the web
About Oaktree Specialty Lending Corp
CEO-
Employees0
Founded2007
HeadquartersLos Angeles, California, United States
SectorCapital market
Analyst ratings
Based on 1 analyst giving stock ratings to OCSL in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for OCSL in the last 3 months
Highest
Current $11.69
$13.00 (+11.21%)
Average
$13.00 (+11.21%)
Lowest
$13.00 (+11.21%)
Analyst
Recommendation
Action
Price target
Projected
Date
Mitchel Penn
Oppenheimer
Hold
Reiterated
$13.00
+11.2%
05/06/2026
Unknown Analyst
Oppenheimer
Hold
Reiterated
$13.00
+11.2%
05/06/2026
Richard Shane
J.P. Morgan
Hold
Maintained
$10.50
-10.2%
03/13/2026
Finian O'Shea
Wells Fargo
Hold
Maintained
$12.00
+2.7%
02/05/2026
Paul Johnson
KBW
Hold
Maintained
$13.50
+15.5%
02/05/2026
Ethan Kaye
Lucid Capital
Hold
Initiated
$13.75
+17.6%
12/15/2025
Last report
May 5, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$0.38 / $0.37
+3.77%beat
Revenue / Est. (USD)
70.38M / 74.46M
-5.47%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
Revenue
Cost of goods sold
Cost of revenue
Research and development expenses
Total research and development expenses
Selling, general, and admin expenses
Operating expense
Total operating expenses
Operating income
Other non operating income
EBT including unusual items
EBT excluding unusual items
Income tax expense
Effective tax rate
Other operating expenses
Net income
Net profit margin
Earnings per share
Interest and investment income
Interest expense
Net interest expenses
Depreciation and amortization charges
EBITDA
Gain or loss from assets sale
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
Give me an overview of OCSL
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more